Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science by C. DavisUnhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science by C. Davis

Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science

byC. Davis, J. Abraham

Hardcover | November 8, 2013

Pricing and Purchase Info

$132.29 online 
$149.50 list price save 11%
Earn 661 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health.

Courtney Davis is Senior Lecturer in Sociology at Kings College London, UK. Previously Director of the Centre for Corporate Accountability, she is author of Making Companies Safe. John Abraham is Professor of Sociology at Kings College London, UK. Author of over 100 publications on pharmaceuticals in society, he was Special Expert Adv...
Title:Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory ScienceFormat:HardcoverDimensions:336 pages, 8.5 × 5.51 × 0.03 inPublished:November 8, 2013Publisher:Palgrave Macmillan UKLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0230008666

ISBN - 13:9780230008663

Look for similar items by category:

Customer Reviews of Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science

Reviews

Table of Contents

1. Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health

2. The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era

3. Designs on Diabetes Drugs

4. Desperate Regulation for Desperate Cancer Patients

5. The Making of a Harmful 'Therapeutic Breakthrough'

6. The Regulatory Science and Politics of Risk Management

7. Conclusions and Policy Implications